Related Experiment Videos
Lymphocytes forming stable E-rosettes in acute and chronic hepatitis.
Clinical and Experimental Immunology
|March 1, 1979
Summary
Increased E-rosette forming lymphocytes, a type of T-lymphocyte with suppressor function, were found in patients with acute hepatitis B and HBsAg-negative chronic hepatitis. These cells were not elevated in HBsAg-positive chronic hepatitis cases.
Area of Science:
- Immunology
- Hepatology
- Virology
Background:
- Hepatitis B virus (HBV) infection can lead to acute and chronic liver disease.
- Specific lymphocyte subpopulations may play a role in the immune response to HBV.
- E-rosette forming lymphocytes (ERFs) are a subset of T-lymphocytes with potential immunoregulatory functions.
Purpose of the Study:
- To investigate the presence and characteristics of E-rosette forming lymphocytes in patients with different forms of hepatitis B.
- To determine if ERFs correlate with specific hepatitis B virus (HBV) antigens or disease activity.
Main Methods:
- Peripheral blood lymphocytes were isolated from patients with acute hepatitis B, HBsAg-negative active chronic hepatitis, and HBsAg-positive active chronic hepatitis.
- E-rosette formation with sheep erythrocytes was assessed.
- Lymphocyte adherence to nylon wool and Fc-gamma-G (FcIgG) receptor expression were evaluated.
Main Results:
- Elevated numbers of E-rosette forming lymphocytes were observed in patients with acute hepatitis B (6-20%) and HBsAg-negative active chronic hepatitis (9-28%).
- No significant increase in ERFs was found in patients with HBsAg-positive active chronic hepatitis.
- These ERFs exhibited properties consistent with a T-lymphocyte subpopulation, including nylon wool adherence and FcIgG receptor expression.
Conclusions:
- A specific subpopulation of T-lymphocytes with suppressor function, identified by E-rosette formation, is increased in acute hepatitis B and HBsAg-negative chronic hepatitis.
- The absence of this increase in HBsAg-positive chronic hepatitis suggests a differential immune response based on viral antigen status.